The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
18f-FDG-PET imaging as an early survival predictor in patients with high-grade soft tissue sarcomas undergoing neoadjuvant therapy.
Ken Herrmann
No relevant relationships to disclose
Matthias R. Benz
No relevant relationships to disclose
Johannes Czernin
No relevant relationships to disclose
Martin Auerbach
No relevant relationships to disclose
William D. Tap
No relevant relationships to disclose
Sarah M Dry
No relevant relationships to disclose
Tibor Schuster
No relevant relationships to disclose
Jeff J. Eckardt
No relevant relationships to disclose
Michael E. Phelps
No relevant relationships to disclose
Frederick C. Eilber
No relevant relationships to disclose